Siyomicro Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$14.7M
- Investors
-
7
Siyomicro General Information
Description
Developer of synthetic biology technologies designed to advance the production of bioactive ingredients and microbial-based products. The company offers microbial enzyme development, extreme-environment microorganism resources, genome databases, and bioactive compounds, enabling pharmaceutical, healthcare, food, and personal care companies to develop biotechnology-based products with enhanced research and manufacturing capabilities.
Contact Information
Website
www.siyobio.comCorporate Office
- Precision Digital Culture Industrial Park, C801-C812, Number 39 Qingfeng Avenue
- Baolong Street, Baolong Community, Longgang District
- Shenzhen, Guangdong 518116
- China
Corporate Office
- Precision Digital Culture Industrial Park, C801-C812, Number 39 Qingfeng Avenue
- Baolong Street, Baolong Community, Longgang District
- Shenzhen, Guangdong 518116
- China
Siyomicro Timeline
Siyomicro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series C) | 26-Jul-2026 | $14.7M | Completed | Generating Revenue | ||
| 7. Secondary Transaction - Private | 08-Aug-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 27-Dec-2023 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 14-Jul-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 07-Feb-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A1) | 01-Jun-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 28-Sep-2019 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jun-2017 | Completed | Generating Revenue |
Siyomicro Patents
Siyomicro Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025035987-A1 | Preparation and use of high-selectivity adsorption anion resin for ergothioneine | Inactive | 15-Aug-2023 |
Siyomicro Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Goldport Capital | Venture Capital | Minority | ||
| Shenzhen Longgang Financial Holding | Venture Capital | Minority | ||
| Aier Eye Hospital Group | Corporation | Minority | ||
| Aier Healthcare Investment | Corporate Venture Capital | Minority | ||
| Aramco Ventures | Corporate Venture Capital | Minority |
Siyomicro FAQs
-
When was Siyomicro founded?
Siyomicro was founded in 2015.
-
Where is Siyomicro headquartered?
Siyomicro is headquartered in Shenzhen, China.
-
What industry is Siyomicro in?
Siyomicro’s primary industry is Biotechnology.
-
Is Siyomicro a private or public company?
Siyomicro is a Private company.
-
What is Siyomicro’s current revenue?
The current revenue for Siyomicro is .
-
How much funding has Siyomicro raised over time?
Siyomicro has raised $60.2M.
-
Who are Siyomicro’s investors?
Goldport Capital, Shenzhen Longgang Financial Holding, Aier Eye Hospital Group, Aier Healthcare Investment, and Aramco Ventures are 5 of 7 investors who have invested in Siyomicro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process